Trump tables AHCA negotiations, calls for a vote | How does drug pricing work? | Rare skin cancer drug from Merck, Pfizer wins FDA nod
March 24, 2017
FOLLOW PCMA ON TWITTER  Twitter
PCMA SmartBrief
News for the PBM Industry
SIGN UP ⋅   FORWARD ⋅   ARCHIVE
Featured Story
Trump tables AHCA negotiations, calls for a vote
Trump tables AHCA negotiations, calls for a vote.
(Win McNamee/Getty Images)
After Thursday's planned vote on the American Health Care Act was delayed, President Donald Trump told House Republicans they must vote on and support the measure today, or he will move on to other policy priorities. The Rules Committee is expected to meet this morning to determine terms for debate, with a vote planned for afternoon.
The Wall Street Journal (tiered subscription model) (3/23),  CQ.com (subscription required) (3/23),  Reuters (3/24),  National Public Radio (3/23) 
LinkedIn Twitter Facebook Google+ Email
 
Legislative & Regulatory News
Rare skin cancer drug from Merck, Pfizer wins FDA nod
Pfizer and Merck KGaA's Bavencio, or avelumab, has received FDA approval as a treatment for patients at least 12 years old with metastatic Merkel cell carcinoma.
Reuters (3/23) 
LinkedIn Twitter Facebook Google+ Email
Apicore's generic Xenazine receives FDA approval
Apicore's abbreviated new drug application for tetrabenazine tablets has been approved by the FDA. The drug, which is indicated for patients with involuntary movements of Huntington's disease, is a generic version of Valeant Pharmaceuticals' Xenazine.
Seeking Alpha (free registration) (3/23) 
LinkedIn Twitter Facebook Google+ Email
Drug Industry Spotlight
Pfizer CEO: Europe gets free ride from US pharma
Pfizer CEO Ian Read said national health systems in Europe are taking advantage of innovative drugs developed by US pharmaceutical companies, a contrast with President Donald Trump's past statements that foreign countries get better deals than the US and that Medicare and Medicaid should be able to negotiate drug prices.
STAT (tiered subscription model) (3/23) 
LinkedIn Twitter Facebook Google+ Email
  
  
We do not need magic to change the world. We carry all the power we need inside ourselves already: We have the power to imagine better.
J.K. Rowling,
writer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about PCMA:
Upcoming PCMA Events | PCMA Newsroom
Become a PCMA Affiliate
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

Contact PCMA
Charles Cote
Vice President, Strategic Communications
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information